Science News
from research organizations

First Functional Insulin-binding Protein In Invertebrates

Date:
April 18, 2008
Source:
BioMed Central/Journal of Biology
Summary:
Insulin-like growth factor signaling that helps to regulate mammals' growth, metabolism, reproduction and longevity is well documented. Now research in the Journal of Biology describes the genetic identification of the first functional insulin-like growth factor binding protein ortholog in invertebrates.
Share:
       
FULL STORY

Insulin-like growth factor (IGF) signaling that helps to regulate mammals' growth, metabolism, reproduction and longevity is well documented. Now new research describes the genetic identification of the first functional insulin-like growth factor binding protein (IGFBP) ortholog in invertebrates.

Insulin and insulin-like growth factors (IGFs) signal through a highly conserved pathway and control growth and metabolism in both vertebrates and invertebrates. The well-studied mammalian IGF binding proteins (IGFBPs) do not, however, have obvious sequence homologs in the fruit fly Drosophila. The discovery of a functional ortholog transforms Drosophila into a powerful model system in which to explore metabolic regulation and presents a significant advance in our understanding of the mechanisms by which the actions of insulin-like peptides are regulated.

A research team led by Ernst Hafen from the Institute of Molecular Systems Biology at the ETH in Zürich, Switzerland, employed a genetic strategy to search for negative insulin/insulin-like growth factor signaling (IIS) regulators in Drosophila. The team identified a new functional insulin-binding protein that acts as an IIS antagonist. Dubbed imaginal morphogenesis protein-late 2 (Imp-L2), the new antagonist binds the Drosophila insulin-like peptide 2 (Dilp2), inhibiting its growth-promoting function. Imp-L2 not only has a role in growth regulation - it is also essential for the dampening of insulin signaling under adverse conditions.

The authors hope that better understanding of Imp-L2's role in growth control and insulin signaling in Drosophila will ultimately impact on our understanding of the human ortholog IGFBP-7. This has a regulatory role in pathways that impact upon diabetes and cancer. IGFBP-7 acts as a tumor suppressor in a variety of human organs and differs in the C-terminus from the other IGFBPs.

"Since Imp-L2 and the human tumor suppressor IGFBP-7 display sequence homology in their C-terminal immunoglobulin-like domains, we suggest that their common precursor represents an ancestral insulin-binding protein," says Hafen.

Journal reference:  Imp-L2, a homolog of vertebrate IGF-binding protein 7, counteracts insulin signaling in Drosophila and is essential for starvation resistance. Basil Honegger, Milos Galic, Katja Kohler, Franz Wittwer, Walter Brogiolo, Ernst Hafen and Hugo Stocker. Journal of Biology (in press)


Story Source:

The above post is reprinted from materials provided by BioMed Central/Journal of Biology. Note: Materials may be edited for content and length.


Cite This Page:

BioMed Central/Journal of Biology. "First Functional Insulin-binding Protein In Invertebrates." ScienceDaily. ScienceDaily, 18 April 2008. <www.sciencedaily.com/releases/2008/04/080414193033.htm>.
BioMed Central/Journal of Biology. (2008, April 18). First Functional Insulin-binding Protein In Invertebrates. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2008/04/080414193033.htm
BioMed Central/Journal of Biology. "First Functional Insulin-binding Protein In Invertebrates." ScienceDaily. www.sciencedaily.com/releases/2008/04/080414193033.htm (accessed August 2, 2015).

Share This Page: